Join
Live feed
·
INSIDERFilingvia Quantisnow
Crescent Biopharma Inc. logo

Chief Executive Officer Brumm Joshua T sold $761,067 worth of Ordinary Shares (42,305 units at $17.99) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 281,212 units (SEC Form 4) (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.
CBIO· Crescent Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CBIO (Crescent Biopharma Inc.) and more on Quantisnow.